Grayscale makes Lido the second-heaviest component in its DeFi Fund

Quick Take

  • Staking protocol Lido’s token has been added to Grayscale’s DeFi Fund. 
  • LDO’s weight in the fund sits at 19.04%, second only to Uniswap’s UNI at 45.46%.

Digital asset manager Grayscale added the Lido protocol's LDO token to its DeFi Fund, making it the second-heaviest component.

Grayscale's DeFi Fund is now weighted to include Uniswap (UNI) at 45.46%, Lido (LDO) at 19.04%, Aave (AAVE) at 11.53%, MakerDAO (MKR) at 10.82%, Curve DAO Token (CRV) at 7.03% and Synthetix (SNX) at 6.12%.

"In accordance with the CoinDesk DeFi Select Index methodology, Grayscale has adjusted the DeFi Fund’s portfolio by selling certain amounts of the existing Fund Components in proportion to their respective weightings, and using the cash proceeds to purchase Lido (LDO)," Grayscale said in a company release. "No tokens were removed from the DeFi Fund."

Lido is a decentralized liquid staking protocol that allows users to keep staked tokens liquid via a stand-in token, or stToken.


Keep up with the latest news, trends, charts and views on crypto and DeFi with a new biweekly newsletter from The Block's Frank Chaparro

By signing-up you agree to our Terms of Service and Privacy Policy
By signing-up you agree to our Terms of Service and Privacy Policy

Grayscale redefines the composites of its funds quarterly.


© 2023 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

About Author

MK Manoylov has been a reporter for The Block since 2020 — joining just before bitcoin surpassed $20,000 for the first time. Since then, MK has written nearly 1,000 articles for the publication, covering any and all crypto news but with a penchant toward NFT, metaverse, web3 gaming, funding, crime, hack and crypto ecosystem stories. MK holds a graduate degree from New York University's Science, Health and Environmental Reporting Program (SHERP) and has also covered health topics for WebMD and Insider. You can follow MK on X @MManoylov and on LinkedIn.


To contact the editor of this story:
Nathan Crooks at
[email protected]